Top Key Companies for Multi-Organ-on-a-Chip Models Market: Mimetas, TissUse, CN Bio Innovations, Hesperos, AxoSim, Elvesys, Beijing Abace Biotechnology.
Global Multi-Organ-on-a-Chip Models Market Size was estimated at USD 859.47 million in 2022 and is projected to reach USD 1175 million by 2028, exhibiting a CAGR of 5.35% during the forecast period.
Global Multi-Organ-on-a-Chip Models Market Overview And Scope:
The Global Multi-Organ-on-a-Chip Models Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Multi-Organ-on-a-Chip Models utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Multi-Organ-on-a-Chip Models Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Multi-Organ-on-a-Chip Models portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Multi-Organ-on-a-Chip Models market.
Global Multi-Organ-on-a-Chip Models Market Segmentation
By Type, Multi-Organ-on-a-Chip Models market has been segmented into:
Gut/Liver-on-a-chip Model
Lung/Liver-on-a-chip Model
Nerve/Muscle-on-a-chip Model
Heart/Liver-on-a-chip Model
Others
By Application, Multi-Organ-on-a-Chip Models market has been segmented into:
Pharmaceutical
Research Institute
Others
Regional Analysis of Multi-Organ-on-a-Chip Models Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Multi-Organ-on-a-Chip Models Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Multi-Organ-on-a-Chip Models market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Multi-Organ-on-a-Chip Models market.
Top Key Companies Covered in Multi-Organ-on-a-Chip Models market are:
Mimetas
TissUse
CN Bio Innovations
Hesperos
AxoSim
Elvesys
Beijing Abace Biotechnology
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Multi-Organ-on-a-Chip Models Market by Type
5.1 Multi-Organ-on-a-Chip Models Market Overview Snapshot and Growth Engine
5.2 Multi-Organ-on-a-Chip Models Market Overview
5.3 Gut/Liver-on-a-chip Model
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Gut/Liver-on-a-chip Model: Geographic Segmentation
5.4 Lung/Liver-on-a-chip Model
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Lung/Liver-on-a-chip Model: Geographic Segmentation
5.5 Nerve/Muscle-on-a-chip Model
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Nerve/Muscle-on-a-chip Model: Geographic Segmentation
5.6 Heart/Liver-on-a-chip Model
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Heart/Liver-on-a-chip Model: Geographic Segmentation
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation
Chapter 6: Multi-Organ-on-a-Chip Models Market by Application
6.1 Multi-Organ-on-a-Chip Models Market Overview Snapshot and Growth Engine
6.2 Multi-Organ-on-a-Chip Models Market Overview
6.3 Pharmaceutical
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Pharmaceutical: Geographic Segmentation
6.4 Research Institute
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Research Institute: Geographic Segmentation
6.5 Others
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Multi-Organ-on-a-Chip Models Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Multi-Organ-on-a-Chip Models Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Multi-Organ-on-a-Chip Models Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 MIMETAS
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 TISSUSE
7.4 CN BIO INNOVATIONS
7.5 HESPEROS
7.6 AXOSIM
7.7 ELVESYS
7.8 BEIJING ABACE BIOTECHNOLOGY
Chapter 8: Global Multi-Organ-on-a-Chip Models Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Gut/Liver-on-a-chip Model
8.2.2 Lung/Liver-on-a-chip Model
8.2.3 Nerve/Muscle-on-a-chip Model
8.2.4 Heart/Liver-on-a-chip Model
8.2.5 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Pharmaceutical
8.3.2 Research Institute
8.3.3 Others
Chapter 9: North America Multi-Organ-on-a-Chip Models Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Gut/Liver-on-a-chip Model
9.4.2 Lung/Liver-on-a-chip Model
9.4.3 Nerve/Muscle-on-a-chip Model
9.4.4 Heart/Liver-on-a-chip Model
9.4.5 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Pharmaceutical
9.5.2 Research Institute
9.5.3 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Multi-Organ-on-a-Chip Models Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Gut/Liver-on-a-chip Model
10.4.2 Lung/Liver-on-a-chip Model
10.4.3 Nerve/Muscle-on-a-chip Model
10.4.4 Heart/Liver-on-a-chip Model
10.4.5 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Pharmaceutical
10.5.2 Research Institute
10.5.3 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Multi-Organ-on-a-Chip Models Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Gut/Liver-on-a-chip Model
11.4.2 Lung/Liver-on-a-chip Model
11.4.3 Nerve/Muscle-on-a-chip Model
11.4.4 Heart/Liver-on-a-chip Model
11.4.5 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Pharmaceutical
11.5.2 Research Institute
11.5.3 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Multi-Organ-on-a-Chip Models Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Gut/Liver-on-a-chip Model
12.4.2 Lung/Liver-on-a-chip Model
12.4.3 Nerve/Muscle-on-a-chip Model
12.4.4 Heart/Liver-on-a-chip Model
12.4.5 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Pharmaceutical
12.5.2 Research Institute
12.5.3 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Multi-Organ-on-a-Chip Models Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Gut/Liver-on-a-chip Model
13.4.2 Lung/Liver-on-a-chip Model
13.4.3 Nerve/Muscle-on-a-chip Model
13.4.4 Heart/Liver-on-a-chip Model
13.4.5 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Pharmaceutical
13.5.2 Research Institute
13.5.3 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Multi-Organ-on-a-Chip Models Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Gut/Liver-on-a-chip Model
14.4.2 Lung/Liver-on-a-chip Model
14.4.3 Nerve/Muscle-on-a-chip Model
14.4.4 Heart/Liver-on-a-chip Model
14.4.5 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Pharmaceutical
14.5.2 Research Institute
14.5.3 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Multi-Organ-on-a-Chip Models Scope:
|
Report Data
|
Multi-Organ-on-a-Chip Models Market
|
|
Multi-Organ-on-a-Chip Models Market Size in 2025
|
USD XX million
|
|
Multi-Organ-on-a-Chip Models CAGR 2025 - 2032
|
XX%
|
|
Multi-Organ-on-a-Chip Models Base Year
|
2024
|
|
Multi-Organ-on-a-Chip Models Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Mimetas, TissUse, CN Bio Innovations, Hesperos, AxoSim, Elvesys, Beijing Abace Biotechnology.
|
|
Key Segments
|
By Type
Gut/Liver-on-a-chip Model
Lung/Liver-on-a-chip Model
Nerve/Muscle-on-a-chip Model
Heart/Liver-on-a-chip Model
Others
By Applications
Pharmaceutical
Research Institute
Others
|
